MYC,MYCN stimulate MIR9-3 gene transcription

Stable Identifier
R-HSA-9816148
Type
Reaction [omitted]
Species
Homo sapiens
Compartment
ReviewStatus
3/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
MYC and MYCN positively regulate expression of miR-9 (Ma et al. 2010; Liu et al. 2013; DA Silva Oliveira et al. 2017). When MYC is ectopically expressed in human mammary epithelial cell line HMLE, increase in MYC expression level correlates with an increase in the level of mature miR-9. miR-9 can be generated by the processing of any of three primary transcripts encoded by three distinct genes, MIR9-1, MIR9-2, and MIR9-3. Among the three encoding genes, the transcription of miR-9-3 is upregulated most strongly by the MYC transcription factor. When an inducible MYCN-ER fusion protein is expressed in human neuroblastoma cell line SHEP, miR-9 expression level increases comparable to the increase in the expression of the miR-17-92 positive control, whose expression is known to be activated by MYCN through direct promoter binding. MYC binding at the MIR9-3 locus is associated with elevated H3K4me3 at the MIR9-3 locus, a marker of transcriptionally active chromatin binding. While a peak for MYC binding was also observed at MIR9-1 and MIR9-2 loci, these two regions exhibited low occupancy by H3K4me3 (a mark of activated chromatin) and relatively high occupancy by H3K27me3 (a mark of repressed chromatin). Hence, among the three miR-9-encoding genes, the transcription of mir-9-3 is the most responsive to transcriptional activation by MYC/MYCN. In a group of over twenty stage 4 neuroblastoma tumors, tumors with MYCN gene amplification showed more than twofold upregulation of miR-9 expression relative to tumors with no MYCN gene amplification (Ma et al. 2010). Induced overexpression of MYC in human embryonic kidney cell line HEK293 leads to upregulation of miR-9 (Liu et al. 2013). In gastric cancer, MYC amplification correlates with overexpression of miR-9 (DA Silva Oliveira et al. 2017). MYC was also shown to be enriched on the promoter of the MIR9-1 gene by ChIP in human fibroblast cell lines HFL-1 and MRC-5 and to stimulate miR-9-1 expression in both mouse and human (Qin et al. 2022).
Literature References
PubMed ID Title Journal Year
28476807 Expression of hsa-miR-9 and MYC Copy Number Variation in Hereditary Diffuse Gastric Cancer

DA Silva Oliveira, KC, Bona, AB, DA Silva, FJ, Pinheiro, TM, DI Felipe Avila Alcantara, D, Lamarao, LM, Moreira-Nunes, CA, Assumpcao, PP, Burbano, RR, Calcagno, DQ

Anticancer Res 2017
23364919 c-Myc suppressed E-cadherin through miR-9 at the post-transcriptional level

Liu, M, Zhu, H, Yang, S, Wang, Z, Bai, J, Xu, N

Cell Biol Int 2013
35122989 C-MYC induces idiopathic pulmonary fibrosis via modulation of miR-9-5p-mediated TBPL1

Qin, H, Tang, Y, Mao, Y, Zhou, X, Xu, T, Liu, W, Su, X

Cell Signal 2022
20173740 miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

Ma, L, Young, J, Prabhala, H, Pan, E, Mestdagh, P, Muth, D, Teruya-Feldstein, J, Reinhardt, F, Onder, TT, Valastyan, S, Westermann, F, Speleman, F, Vandesompele, J, Weinberg, RA

Nat Cell Biol 2010
Participants
Participates
This event is regulated
Authored
Created
Cite Us!